Current Urology Reports

, Volume 14, Issue 4, pp 315–326

Fertility Preservation in the Male with Cancer

Men's Health (J Mulhall, Section Editor)


This article reviews the current concepts, recommendations, and principles of fertility preservation in men with cancer. Obstacles to sperm banking are addressed, as well as future directions for fertility-preserving technologies. All cancer therapies—chemotherapy, radiation, and surgery—are potential threats to a man’s reproductive potential. Additionally, cancer itself can impair spermatogenesis. Thus, sperm cryopreservation prior to initiating life-saving cancer treatment offers men and their families the best chances to father biologically-related children and should be offered to all men with cancer before treatment. Better patient and provider education, as well as deliberate, coordinated strategies at comprehensive cancer care centers, are necessary to make fertility preservation for male cancer patients a priority during pre-treatment planning.


Semen Cryopreservation Semen preservation Male infertility Sperm banks Spermatozoa Neoplasms Assisted reproductive techniques 


  1. 1.
    Agarwal A, Ranganathan P, Kattal N, Pasqualotto F, Hallak J, Khayal S, et al. Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens. Fertil Steril. 2004;81(2):342–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Lass A, Akagbosu F, Brinsden P. Sperm banking and assisted reproduction treatment for couples following cancer treatment of the male partner. Hum Reprod Update. 2001;7(4):370–7.PubMedCrossRefGoogle Scholar
  3. 3.
    McVie JG. Cancer treatment: the last 25 years. Cancer Treat Rev. 1999;25(6):323–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet. 2004;364(9451):2097–105.PubMedCrossRefGoogle Scholar
  5. 5.
    Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA, Cosgrove MD. Long-term effects of testicular cancer on sexual functioning in married couples. Cancer. 1989;64(7):1560–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Hartmann JT, Albrecht C, Schmoll HJ, Kuczyk MA, Kollmannsberger C, Bokemeyer C. Long-term effects on sexual function and fertility after treatment of testicular cancer. Br J Cancer. 1999;80(5–6):801–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Mackie E, Hill J, Kondryn H, McNally R. Adult psychosocial outcomes in long-term survivors of acute lymphoblastic leukaemia and Wilms’ tumour: a controlled study. Lancet. 2000;355(9212):1310–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Rieker PP, Fitzgerald EM, Kalish LA. Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol. 1990;8(2):347–55.PubMedGoogle Scholar
  9. 9.
    Rieker PP, Fitzgerald EM, Kalish LA, Richie JP, Lederman GS, Edbril SD, et al. Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer. 1989;64(11):2399–407.PubMedCrossRefGoogle Scholar
  10. 10.
    Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer. 2005;104(3):521–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer. 1999;86(4):697–709.PubMedCrossRefGoogle Scholar
  12. 12.
    Agarwal A. Semen banking in patients with cancer: 20-year experience. Int J Androl. 2000;23 Suppl 2:16–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Audrins P, Holden CA, McLachlan RI, Kovacs GT. Semen storage for special purposes at Monash IVF from 1977 to 1997. Fertil Steril. 1999;72(1):179–81.PubMedCrossRefGoogle Scholar
  14. 14.
    Bahadur G, Ling KL, Hart R, Ralph D, Wafa R, Ashraf A, et al. Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod. 2002;17(12):3157–61.PubMedCrossRefGoogle Scholar
  15. 15.
    Fossa SD, Aass N, Molne K. Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer? Br J Urol. 1989;64(5):524–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Kelleher S, Wishart SM, Liu PY, Turner L, Di Pierro I, Conway AJ, et al. Long-term outcomes of elective human sperm cryostorage. Hum Reprod. 2001;16(12):2632–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Lass A, Akagbosu F, Abusheikha N, Hassouneh M, Blayney M, Avery S, et al. A programme of semen cryopreservation for patients with malignant disease in a tertiary infertility centre: lessons from 8 years’ experience. Hum Reprod. 1998;13(11):3256–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Naysmith TE, Blake DA, Harvey VJ, Johnson NP. Do men undergoing sterilizing cancer treatments have a fertile future? Hum Reprod. 1998;13(11):3250–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Saito K, Suzuki K, Noguchi K, Ogawa T, Takeda M, Hosaka M, et al. Semen cryopreservation for patients with malignant or non-malignant disease: our experience for 10 years. Nippon Hinyokika Gakkai Zasshi. 2003;94(4):513–20.PubMedGoogle Scholar
  20. 20.
    Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer–criteria change. Fertil Steril. 1992;58(5):1024–7.PubMedGoogle Scholar
  21. 21.
    Agarwal A, Allamaneni SS. Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr. 2005;34:9–12.PubMedCrossRefGoogle Scholar
  22. 22.
    Petersen PM, Skakkebaek NE, Rorth M, Giwercman A. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J Urol. 1999;161(3):822–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Petersen PM, Skakkebaek NE, Vistisen K, Rorth M, Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol. 1999;17(3):941–7.PubMedGoogle Scholar
  24. 24.
    Rueffer U, Breuer K, Josting A, Lathan B, Sieber M, Manzke O, et al. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol. 2001;12(9):1307–11.PubMedCrossRefGoogle Scholar
  25. 25.
    Colpi GM, Contalbi GF, Nerva F, Sagone P, Piediferro G. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol. 2004;113 Suppl 1:S2–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Hallak J, Kolettis PN, Sekhon VS, Thomas Jr AJ, Agarwal A. Sperm cryopreservation in patients with testicular cancer. Urology. 1999;54(5):894–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Rofeim O, Gilbert BR. Normal semen parameters in cancer patients presenting for cryopreservation before gonadotoxic therapy. Fertil Steril. 2004;82(2):505–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Bahadur G, Ozturk O, Muneer A, Wafa R, Ashraf A, Jaman N, et al. Semen quality before and after gonadotoxic treatment. Hum Reprod. 2005;20(3):774–81.PubMedCrossRefGoogle Scholar
  29. 29.
    Ragni G, Somigliana E, Restelli L, Salvi R, Arnoldi M, Paffoni A. Sperm banking and rate of assisted reproduction treatment: insights from a 15-year cryopreservation program for male cancer patients. Cancer. 2003;97(7):1624–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Williams DHT, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol. 2009;181(2):736–40.PubMedCrossRefGoogle Scholar
  31. 31.
    Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol. 2004;113 Suppl 1:S7–11.PubMedCrossRefGoogle Scholar
  32. 32.
    Meseguer M, Molina N, Garcia-Velasco JA, Remohi J, Pellicer A, Garrido N. Sperm cryopreservation in oncological patients: a 14-year follow-up study. Fertil Steril. 2006;85(3):640–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Hendry WF, Stedronska J, Jones CR, Blackmore CA, Barrett A, Peckham MJ. Semen analysis in testicular cancer and Hodgkin’s disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol. 1983;55(6):769–73.PubMedCrossRefGoogle Scholar
  34. 34.
    Viviani S, Bonfante V, Santoro A, Zanini M, Devizzi L, Di Russo AD, et al. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin’s disease. Cancer J Sci Am. 1999;5(5):275–82.PubMedGoogle Scholar
  35. 35.
    Hotaling JM, Lopushnyan NA, Davenport M, Christensen H, Pagel ER, Muller CH, et al. Raw and test-thaw semen parameters after cryopreservation among men with newly diagnosed cancer. Fertil Steril. 2013;99(2):464-9.PubMedCrossRefGoogle Scholar
  36. 36.
    Rives N, Perdrix A, Hennebicq S, Saias-Magnan J, Melin MC, Berthaut I, et al. The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network. J Androl. 2012;33(6):1394-401.PubMedCrossRefGoogle Scholar
  37. 37.
    Berthelsen JG, Skakkebaek NE. Gonadal function in men with testis cancer. Fertil Steril. 1983;39(1):68–75.PubMedGoogle Scholar
  38. 38.
    Stahl O, Eberhard J, Cavallin-Stahl E, Jepson K, Friberg B, Tingsmark C, et al. Sperm DNA integrity in cancer patients: the effect of disease and treatment. Int J Androl. 2008 Oct 30.Google Scholar
  39. 39.
    Apperley JF, Reddy N. Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev. 1995;9(2):93–116.PubMedCrossRefGoogle Scholar
  40. 40.
    Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005;34:12–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Spitz S. The histological effects of nitrogen mustards on human tumors and tissues. Cancer. 1948;1(3):383–98.PubMedCrossRefGoogle Scholar
  42. 42.
    Schrader M, Muller M, Straub B, Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol. 2001;15(6):611–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Meirow D, Schenker JG. Cancer and male infertility. Hum Reprod. 1995;10(8):2017–22.PubMedGoogle Scholar
  44. 44.
    Carson SA, Gentry WL, Smith AL, Buster JE. Feasibility of semen collection and cryopreservation during chemotherapy. Hum Reprod. 1991;6(7):992–4.PubMedGoogle Scholar
  45. 45.
    Pont J, Albrecht W. Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril. 1997;68(1):1–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Leonard M, Hammelef K, Smith GD. Fertility considerations, counseling, and semen cryopreservation for males prior to the initiation of cancer therapy. Clin J Oncol Nurs. 2004;8(2):127–31, 45.PubMedCrossRefGoogle Scholar
  47. 47.
    Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21(5):601–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.PubMedCrossRefGoogle Scholar
  49. 49.
    Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91(3):613–21.PubMedCrossRefGoogle Scholar
  50. 50.
    Cespedes RD, Peretsman SJ, Thompson Jr IM, Jackson C. Protection of the germinal epithelium in the rat from the cytotoxic effects of chemotherapy by a luteinizing hormone-releasing hormone agonist and antiandrogen therapy. Urology. 1995;46(5):688–91.PubMedCrossRefGoogle Scholar
  51. 51.
    Kreuser ED, Klingmuller D, Thiel E. The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation. Eur Urol. 1993;23(1):157–63. discussion 63-4.PubMedGoogle Scholar
  52. 52.
    Lushbaugh CC, Casarett GW. The effects of gonadal irradiation in clinical radiation therapy: a review. Cancer. 1976;37(2 Suppl):1111–25.PubMedCrossRefGoogle Scholar
  53. 53.
    Trottmann M, Becker AJ, Stadler T, Straub J, Soljanik I, Schlenker B, et al. Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation. Eur Urol. 2007;52(2):355–67.PubMedCrossRefGoogle Scholar
  54. 54.
    Leiper AD, Grant DB, Chessells JM. Gonadal function after testicular radiation for acute lymphoblastic leukaemia. Arch Dis Child. 1986;61(1):53–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Speiser B, Rubin P, Casarett G. Aspermia following lower truncal irradiation in Hodgkin’s disease. Cancer. 1973;32(3):692–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Fossa SD, Ous S, Abyholm T, Norman N, Loeb M. Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol. 1985;57(2):210–4.PubMedCrossRefGoogle Scholar
  57. 57.
    Donohue JP. Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT). Urol Oncol. 2003;21(2):129–32.PubMedCrossRefGoogle Scholar
  58. 58.
    Large MC, Sheinfeld J, Eggener SE. Retroperitoneal lymph node dissection: reassessment of modified templates. BJU Int. 2009;104(9 Pt B):1369–75.PubMedCrossRefGoogle Scholar
  59. 59.
    Shin D, Lipshultz LI, Goldstein M, Barme GA, Fuchs EF, Nagler HM, et al. Herniorrhaphy with polypropylene mesh causing inguinal vasal obstruction: a preventable cause of obstructive azoospermia. Ann Surg. 2005;241(4):553–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Jones OM, Stevenson AR, Stitz RW, Lumley JW. Preservation of sexual and bladder function after laparoscopic rectal surgery. Colorectal Dis. 2009;11(5):489–95.PubMedCrossRefGoogle Scholar
  61. 61.
    Giwercman A, Petersen PM. Cancer and male infertility. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14(3):453–71.PubMedCrossRefGoogle Scholar
  62. 62.
    Jacobsen KD, Olsen DR, Fossa K, Fossa SD. External beam abdominal radiotherapy in patients with seminoma stage I: field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys. 1997;38(1):95–102.PubMedCrossRefGoogle Scholar
  63. 63.
    Gandini L, Sgro P, Lombardo F, Paoli D, Culasso F, Toselli L, et al. Effect of chemo- or radiotherapy on sperm parameters of testicular cancer patients. Hum Reprod. 2006;21(11):2882–9.PubMedCrossRefGoogle Scholar
  64. 64.
    Huyghe E, Matsuda T, Daudin M, Chevreau C, Bachaud JM, Plante P, et al. Fertility after testicular cancer treatments: results of a large multicenter study. Cancer. 2004;100(4):732–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Spermon JR, Ramos L, Wetzels AM, Sweep CG, Braat DD, Kiemeney LA, et al. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum Reprod. 2006;21(7):1781–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Tournaye H, Liu J, Nagy PZ, Camus M, Goossens A, Silber S, et al. Correlation between testicular histology and outcome after intracytoplasmic sperm injection using testicular spermatozoa. Hum Reprod. 1996;11(1):127–32.PubMedCrossRefGoogle Scholar
  67. 67.
    Magelssen H, Brydoy M, Fossa SD. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol. 2006;3(6):312–22.PubMedCrossRefGoogle Scholar
  68. 68.
    Brydoy M, Fossa SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, et al. Paternity following treatment for testicular cancer. J Natl Cancer Inst. 2005;97(21):1580–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, et al. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93(2):200–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997;15(1):239–45.PubMedGoogle Scholar
  71. 71.
    Joos H, Sedlmayer F, Gomahr A, Rahim HB, Frick J, Kogelnik HD, et al. Endocrine profiles after radiotherapy in stage I seminoma: impact of two different radiation treatment modalities. Radiother Oncol. 1997;43(2):159–62.PubMedCrossRefGoogle Scholar
  72. 72.
    Nalesnik JG, Sabanegh Jr ES, Eng TY, Buchholz TA. Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol. 2004;27(6):584–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Classen J, Dieckmann K, Bamberg M, Souchon R, Kliesch S, Kuehn M, et al. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer. 2003;88(6):828–31.PubMedCrossRefGoogle Scholar
  74. 74.
    da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, et al. Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of MOPP chemotherapy. J Clin Oncol. 1984;2(6):571–7.PubMedGoogle Scholar
  75. 75.
    Marmor D, Duyck F. Male reproductive potential after MOPP therapy for Hodgkin’s disease: a long-term survey. Andrologia. 1995;27(2):99–106.PubMedCrossRefGoogle Scholar
  76. 76.
    Tal R, Botchan A, Hauser R, Yogev L, Paz G, Yavetz H. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod. 2000;15(9):1985–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Anserini P, Chiodi S, Spinelli S, Costa M, Conte N, Copello F, et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant. 2002;30(7):447–51.PubMedCrossRefGoogle Scholar
  78. 78.
    Jacob A, Barker H, Goodman A, Holmes J. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transplant. 1998;22(3):277–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Boyd BG, McCallum SW, Lewis RW, Terris MK. Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment. Urology. 2006;68(4):840–4.PubMedCrossRefGoogle Scholar
  80. 80.
    Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML. Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol. 2007;178(5):1933–7. discussion 7-8.PubMedCrossRefGoogle Scholar
  81. 81.
    Daniell HW, Tam EW. Testicular atrophy in therapeutic orchiectomy specimens from men with prostate carcinoma: association with prior prostate bed radiation and older age. Cancer. 1998;83(6):1174–9.PubMedCrossRefGoogle Scholar
  82. 82.
    Mydlo JH, Lebed B. Does brachytherapy of the prostate affect sperm quality and/or fertility in younger men? Scand J Urol Nephrol. 2004;38(3):221–4.PubMedCrossRefGoogle Scholar
  83. 83.
    Raviv G, Pinthus JH, Shefi S, Mor Y, Kaufman-Francis K, Levron J, et al. Effects of intravesical chemotherapy and immunotherapy on semen analysis. Urology. 2005;65(4):765–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Colombo R, Bertini R, Salonia A, Da Pozzo LF, Montorsi F, Brausi M, et al. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J Urol. 2001;165(1):51–5. discussion 5.PubMedCrossRefGoogle Scholar
  85. 85.
    Hyer S, Vini L, O’Connell M, Pratt B, Harmer C. Testicular dose and fertility in men following I(131) therapy for thyroid cancer. Clin Endocrinol (Oxf). 2002;56(6):755–8.PubMedCrossRefGoogle Scholar
  86. 86.
    Longhi A, Macchiagodena M, Vitali G, Bacci G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol. 2003;25(4):292–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Mansky P, Arai A, Stratton P, Bernstein D, Long L, Reynolds J, et al. Treatment late effects in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer. 2007;48(2):192–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Hawkins MM, Draper GJ, Smith RA. Cancer among 1,348 offspring of survivors of childhood cancer. Int J Cancer. 1989;43(6):975–8.PubMedCrossRefGoogle Scholar
  89. 89.
    Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, et al. Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology. N Engl J Med. 1998;338(19):1339–44.PubMedCrossRefGoogle Scholar
  90. 90.
    Winther JF, Boice Jr JD, Mulvihill JJ, Stovall M, Frederiksen K, Tawn EJ, et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet. 2004;74(6):1282–5.PubMedCrossRefGoogle Scholar
  91. 91.
    Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier HU, Cassel MJ, et al. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet. 1997;16(1):74–8.PubMedCrossRefGoogle Scholar
  92. 92.
    Wyrobek AJ, Schmid TE, Marchetti F. Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies. J Natl Cancer Inst Monogr. 2005;34:31–5.PubMedCrossRefGoogle Scholar
  93. 93.
    De Mas P, Daudin M, Vincent MC, Bourrouillou G, Calvas P, Mieusset R, et al. Increased aneuploidy in spermatozoa from testicular tumour patients after chemotherapy with cisplatin, etoposide and bleomycin. Hum Reprod. 2001;16(6):1204–8.PubMedCrossRefGoogle Scholar
  94. 94.
    Frias S, Van Hummelen P, Meistrich ML, Lowe XR, Hagemeister FB, Shelby MD, et al. NOVP chemotherapy for Hodgkin’s disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, Y, 18, and 21. Cancer Res. 2003;63(1):44–51.PubMedGoogle Scholar
  95. 95.
    Thomas C, Cans C, Pelletier R, De Robertis C, Hazzouri M, Sele B, et al. No long-term increase in sperm aneuploidy rates after anticancer therapy: sperm fluorescence in situ hybridization analysis in 26 patients treated for testicular cancer or lymphoma. Clin Cancer Res. 2004;10(19):6535–43.PubMedCrossRefGoogle Scholar
  96. 96.
    Martin R. Human sperm chromosome complements in chemotherapy patients and infertile men. Chromosoma. 1998;107(6–7):523–7.PubMedCrossRefGoogle Scholar
  97. 97.
    WHO, editor. WHO Laboratory Manual for the Examination of Human Semen and Semen–Cervical Mucus Interaction. 4th ed. Cambridge: Cambridge University Press; 1999.Google Scholar
  98. 98.
    Padron OF, Sharma RK, Thomas Jr AJ, Agarwal A. Effects of cancer on spermatozoa quality after cryopreservation: a 12-year experience. Fertil Steril. 1997;67(2):326–31.PubMedCrossRefGoogle Scholar
  99. 99.
    Bolten M, Weissbach L, Kaden R. Cryopreserved human sperm deposits: usability after decades of storage. Urologe A. 2005;44(8):904–8.PubMedCrossRefGoogle Scholar
  100. 100.
    Gandini L, Lombardo F, Lenzi A, Spano M, Dondero F. Cryopreservation and sperm DNA integrity. Cell Tissue Bank. 2006;7(2):91–8.PubMedCrossRefGoogle Scholar
  101. 101.
    Meyers SA. Dry storage of sperm: applications in primates and domestic animals. Reprod Fertil Dev. 2006;18(1–2):1–5.PubMedCrossRefGoogle Scholar
  102. 102.
    Kuczynski W, Dhont M, Grygoruk C, Grochowski D, Wolczynski S, Szamatowicz M. The outcome of intracytoplasmic injection of fresh and cryopreserved ejaculated spermatozoa–a prospective randomized study. Hum Reprod. 2001;16(10):2109–13.PubMedCrossRefGoogle Scholar
  103. 103.
    Shin D, Lo KC, Lipshultz LI. Treatment options for the infertile male with cancer. J Natl Cancer Inst Monogr. 2005;34:48–50.PubMedCrossRefGoogle Scholar
  104. 104.
    Meistrich ML. Potential genetic risks of using semen collected during chemotherapy. Hum Reprod. 1993;8(1):8–10.PubMedGoogle Scholar
  105. 105.
    Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol. 2002;20(7):1880–9.PubMedCrossRefGoogle Scholar
  106. 106.
    Dohle GR, Colpi GM, Hargreave TB, Papp GK, Jungwirth A, Weidner W. EAU guidelines on male infertility. Eur Urol. 2005;48(5):703–11.PubMedCrossRefGoogle Scholar
  107. 107.
    Edge B, Holmes D, Makin G. Sperm banking in adolescent cancer patients. Arch Dis Child. 2006;91(2):149–52.PubMedCrossRefGoogle Scholar
  108. 108.
    Schover LR, Brey K, Lichtin A, Lipshultz LI, Jeha S. Oncologists’ attitudes and practices regarding banking sperm before cancer treatment. J Clin Oncol. 2002;20(7):1890–7.PubMedCrossRefGoogle Scholar
  109. 109.
    Magelssen H, Haugen TB, von During V, Melve KK, Sandstad B, Fossa SD. Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it? Eur Urol. 2005;48(5):779–85.PubMedCrossRefGoogle Scholar
  110. 110.
    Reebals JF, Brown R, Buckner EB. Nurse practice issues regarding sperm banking in adolescent male cancer patients. J Pediatr Oncol Nurs. 2006;23(4):182–8.PubMedCrossRefGoogle Scholar
  111. 111.
    Koeppel KM. Sperm banking and patients with cancer. Issues concerning patients and healthcare professionals. Cancer Nurs. 1995;18(4):306–12.PubMedCrossRefGoogle Scholar
  112. 112.
    Canada AL, Schover LR. Research promoting better patient education on reproductive health after cancer. J Natl Cancer Inst Monogr. 2005;34:98–100.PubMedCrossRefGoogle Scholar
  113. 113.
    Chatterjee R, Haines GA, Perera DM, Goldstone A, Morris ID. Testicular and sperm DNA damage after treatment with fludarabine for chronic lymphocytic leukaemia. Hum Reprod. 2000;15(4):762–6.PubMedCrossRefGoogle Scholar
  114. 114.
    Schuster TG, Hickner-Cruz K, Ohl DA, Goldman E, Smith GD. Legal considerations for cryopreservation of sperm and embryos. Fertil Steril. 2003;80(1):61–6.PubMedCrossRefGoogle Scholar
  115. 115.
    Zebrack BJ, Zeltzer LK. Quality of life issues and cancer survivorship. Curr Probl Cancer. 2003;27(4):198–211.PubMedCrossRefGoogle Scholar
  116. 116.
    Hirsch M, Lunenfeld B, Modan M, Ovadia J, Shemesh J. Spermarche–the age of onset of sperm emission. J Adolesc Health Care. 1985;6(1):35–9.PubMedCrossRefGoogle Scholar
  117. 117.
    Nielsen CT, Skakkebaek NE, Richardson DW, Darling JA, Hunter WM, Jorgensen M, et al. Onset of the release of spermatozoa (spermarche) in boys in relation to age, testicular growth, pubic hair, and height. J Clin Endocrinol Metab. 1986;62(3):532–5.PubMedCrossRefGoogle Scholar
  118. 118.
    Bahadur G, Ling KL, Hart R, Ralph D, Riley V, Wafa R, et al. Semen production in adolescent cancer patients. Hum Reprod. 2002;17(10):2654–6.PubMedCrossRefGoogle Scholar
  119. 119.
    Kliesch S, Behre HM, Jurgens H, Nieschlag E. Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol. 1996;26(1):20–7.PubMedCrossRefGoogle Scholar
  120. 120.
    Ginsberg JP, Ogle SK, Tuchman LK, Carlson CA, Reilly MM, Hobbie WL, et al. Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives. Pediatr Blood Cancer. 2008;50(3):594–8.PubMedCrossRefGoogle Scholar
  121. 121.
    Klosky JL, Randolph ME, Navid F, Gamble HL, Spunt SL, Metzger ML, et al. Sperm cryopreservation practices among adolescent cancer patients at risk for infertility. Pediatr Hematol Oncol. 2009;26(4):252–60.PubMedCrossRefGoogle Scholar
  122. 122.
    Vanderzwalmen P, Zech H, Birkenfeld A, Yemini M, Bertin G, Lejeune B, et al. Intracytoplasmic injection of spermatids retrieved from testicular tissue: influence of testicular pathology, type of selected spermatids and oocyte activation. Hum Reprod. 1997;12(6):1203–13.PubMedCrossRefGoogle Scholar
  123. 123.
    Kim ED, Gilbaugh 3rd JH, Patel VR, Turek PJ, Lipshultz LI. Testis biopsies frequently demonstrate sperm in men with azoospermia and significantly elevated follicle-stimulating hormone levels. J Urol. 1997;157(1):144–6.PubMedCrossRefGoogle Scholar
  124. 124.
    Schrader M, Muller M, Sofikitis N, Straub B, Krause H, Miller K. “Onco-tese”: testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines? Urology. 2003;61(2):421–5.PubMedCrossRefGoogle Scholar
  125. 125.
    Baniel J, Sella A. Sperm extraction at orchiectomy for testis cancer. Fertil Steril. 2001;75(2):260–2.PubMedCrossRefGoogle Scholar
  126. 126.
    Binsaleh S, Sircar K, Chan PT. Feasibility of simultaneous testicular microdissection for sperm retrieval and ipsilateral testicular tumor resection in azoospermic men. J Androl. 2004;25(6):867–71.PubMedGoogle Scholar
  127. 127.
    Choy JT, Wiser HJ, Bell SW, Cashy J, Brannigan RE, Kohler TS. Predictors of spermatogenesis in orchiectomy specimens. Urology. 2013;81(2):288-92.PubMedCrossRefGoogle Scholar
  128. 128.
    Devroey P, Liu J, Nagy Z, Goossens A, Tournaye H, Camus M, et al. Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia. Hum Reprod. 1995;10(6):1457–60.PubMedCrossRefGoogle Scholar
  129. 129.
    Chan PT, Palermo GD, Veeck LL, Rosenwaks Z, Schlegel PN. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistent azoospermia postchemotherapy. Cancer. 2001;92(6):1632–7.PubMedCrossRefGoogle Scholar
  130. 130.
    Damani MN, Master V, Meng MV, Burgess C, Turek P, Oates RD. Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection. J Clin Oncol. 2002;20(4):930–6.PubMedCrossRefGoogle Scholar
  131. 131.
    Meseguer M, Garrido N, Remohi J, Pellicer A, Simon C, Martinez-Jabaloyas JM, et al. Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy. Hum Reprod. 2003;18(6):1281–5.PubMedCrossRefGoogle Scholar
  132. 132.
    Janzen N, Goldstein M, Schlegel PN, Palermo GD, Rosenwaks Z, Hariprashad J. Use of electively cryopreserved microsurgically aspirated epididymal sperm with IVF and intracytoplasmic sperm injection for obstructive azoospermia. Fertil Steril. 2000;74(4):696–701.PubMedCrossRefGoogle Scholar
  133. 133.
    Oates RD, Lobel SM, Harris DH, Pang S, Burgess CM, Carson RS. Efficacy of intracytoplasmic sperm injection using intentionally cryopreserved epididymal spermatozoa. Hum Reprod. 1996;11(1):133–8.PubMedCrossRefGoogle Scholar
  134. 134.
    Ohl DA, Denil J, Bennett CJ, Randolph JF, Menge AC, McCabe M. Electroejaculation following retroperitoneal lymphadenectomy. J Urol. 1991;145(5):980–3.PubMedGoogle Scholar
  135. 135.
    Ohl DA, Wolf LJ, Menge AC, Christman GM, Hurd WW, Ansbacher R, et al. Electroejaculation and assisted reproductive technologies in the treatment of anejaculatory infertility. Fertil Steril. 2001;76(6):1249–55.PubMedCrossRefGoogle Scholar
  136. 136.
    Chung PH, Verkauf BS, Mola R, Skinner L, Eichberg RD, Maroulis GB. Correlation between semen parameters of electroejaculates and achieving pregnancy by intrauterine insemination. Fertil Steril. 1997;67(1):129–32.PubMedCrossRefGoogle Scholar
  137. 137.
    Schatte EC, Orejuela FJ, Lipshultz LI, Kim ED, Lamb DJ. Treatment of infertility due to anejaculation in the male with electroejaculation and intracytoplasmic sperm injection. J Urol. 2000;163(6):1717–20.PubMedCrossRefGoogle Scholar
  138. 138.
    Schmidt KL, Larsen E, Bangsboll S, Meinertz H, Carlsen E, Andersen AN. Assisted reproduction in male cancer survivors: fertility treatment and outcome in 67 couples. Hum Reprod. 2004;19(12):2806–10.PubMedCrossRefGoogle Scholar
  139. 139.
    Ginsburg ES, Yanushpolsky EH, Jackson KV. In vitro fertilization for cancer patients and survivors. Fertil Steril. 2001;75(4):705–10.PubMedCrossRefGoogle Scholar
  140. 140.
    Khalifa E, Oehninger S, Acosta AA, Morshedi M, Veeck L, Bryzyski RG, et al. Successful fertilization and pregnancy outcome in in-vitro fertilization using cryopreserved/thawed spermatozoa from patients with malignant diseases. Hum Reprod. 1992;7(1):105–8.PubMedGoogle Scholar
  141. 141.
    Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;340(8810):17–8.PubMedCrossRefGoogle Scholar
  142. 142.
    Rosenlund B, Sjoblom P, Tornblom M, Hultling C, Hillensjo T. In-vitro fertilization and intracytoplasmic sperm injection in the treatment of infertility after testicular cancer. Hum Reprod. 1998;13(2):414–8.PubMedCrossRefGoogle Scholar
  143. 143.
    Zorn B, Virant-Klun I, Stanovnik M, Drobnic S, Meden-Vrtovec H. Intracytoplasmic sperm injection by testicular sperm in patients with aspermia or azoospermia after cancer treatment. Int J Androl. 2006;29(5):521–7.PubMedCrossRefGoogle Scholar
  144. 144.
    van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90(6):2245–50.PubMedCrossRefGoogle Scholar
  145. 145.
    Borges Jr E, Rossi LM, Locambo de Freitas CV, Guilherme P, Bonetti TC, Iaconelli A, et al. Fertilization and pregnancy outcome after intracytoplasmic injection with fresh or cryopreserved ejaculated spermatozoa. Fertil Steril. 2007;87(2):316–20.PubMedCrossRefGoogle Scholar
  146. 146.
    Ulug U, Bener F, Karagenc L, Ciray N, Bahceci M. Outcomes in couples undergoing ICSI: comparison between fresh and frozen-thawed surgically retrieved spermatozoa. Int J Androl. 2005;28(6):343–9.PubMedCrossRefGoogle Scholar
  147. 147.
    Wald M, Ross LS, Prins GS, Cieslak-Janzen J, Wolf G, Niederberger CS. Analysis of outcomes of cryopreserved surgically retrieved sperm for IVF/ICSI. J Androl. 2006;27(1):60–5.PubMedCrossRefGoogle Scholar
  148. 148.
    Schlatt S, Ehmcke J, Jahnukainen K. Testicular stem cells for fertility preservation: preclinical studies on male germ cell transplantation and testicular grafting. Pediatr Blood Cancer. 2009;53(2):274–80.PubMedCrossRefGoogle Scholar
  149. 149.
    Avarbock MR, Brinster CJ, Brinster RL. Reconstitution of spermatogenesis from frozen spermatogonial stem cells. Nat Med. 1996;2(6):693–6.PubMedCrossRefGoogle Scholar
  150. 150.
    Brinster RL, Avarbock MR. Germline transmission of donor haplotype following spermatogonial transplantation. Proc Natl Acad Sci U S A. 1994;91(24):11303–7.PubMedCrossRefGoogle Scholar
  151. 151.
    Dobrinski I. Germ cell transplantation. Semin Reprod Med. 2005;23(3):257–65.PubMedCrossRefGoogle Scholar
  152. 152.
    Dobrinski I. Germ cell transplantation and testis tissue xenografting in domestic animals. Anim Reprod Sci. 2005;89(1–4):137–45.PubMedCrossRefGoogle Scholar
  153. 153.
    Honaramooz A, Behboodi E, Megee SO, Overton SA, Galantino-Homer H, Echelard Y, et al. Fertility and germline transmission of donor haplotype following germ cell transplantation in immunocompetent goats. Biol Reprod. 2003;69(4):1260–4.PubMedCrossRefGoogle Scholar
  154. 154.
    Izadyar F, Matthijs-Rijsenbilt JJ, den Ouden K, Creemers LB, Woelders H, de Rooij DG. Development of a cryopreservation protocol for type A spermatogonia. J Androl. 2002;23(4):537–45.PubMedGoogle Scholar
  155. 155.
    Nagano M, Patrizio P, Brinster RL. Long-term survival of human spermatogonial stem cells in mouse testes. Fertil Steril. 2002;78(6):1225–33.PubMedCrossRefGoogle Scholar
  156. 156.
    Zhang X, Ebata KT, Nagano MC. Genetic analysis of the clonal origin of regenerating mouse spermatogenesis following transplantation. Biol Reprod. 2003;69(6):1872–8.PubMedCrossRefGoogle Scholar
  157. 157.
    Goossens E, Tournaye H. Testicular stem cells. Semin Reprod Med. 2006;24(5):370–8.PubMedCrossRefGoogle Scholar
  158. 158.
    Jahnukainen K, Ehmcke J, Schlatt S. Testicular xenografts: a novel approach to study cytotoxic damage in juvenile primate testis. Cancer Res. 2006;66(7):3813–8.PubMedCrossRefGoogle Scholar
  159. 159.
    Keros V, Hultenby K, Borgstrom B, Fridstrom M, Jahnukainen K, Hovatta O. Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod. 2007;22(5):1384–95.PubMedCrossRefGoogle Scholar
  160. 160.
    Struijk RB, Mulder CL, van der Veen F, van Pelt AM, Repping S. Restoring fertility in sterile childhood cancer survivors by autotransplanting spermatogonial stem cells: are we there yet? Biomed Res Int. 2013;2013:903142.Google Scholar
  161. 161.
    Jahnukainen K, Hou M, Petersen C, Setchell B, Soder O. Intratesticular transplantation of testicular cells from leukemic rats causes transmission of leukemia. Cancer Res. 2001;61(2):706–10.PubMedGoogle Scholar
  162. 162.
    Feng LX, Chen Y, Dettin L, Pera RA, Herr JC, Goldberg E, et al. Generation and in vitro differentiation of a spermatogonial cell line. Science. 2002;297(5580):392–5.PubMedCrossRefGoogle Scholar
  163. 163.
    Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci U S A. 2003;100(20):11457–62.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of UrologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations